Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens

Child's Nervous System

Volumn 29, Issue 4, 2013, Pages 549-563

  Kim, Young Goo ^a   Jeon, Soyoun ^b   Sin, Ga Yeong ^b   Shim, Jin Kyoung ^a   Kim, Bo Kyung ^a   Shin, Hye Jin ^c   Lee, Ji Hyun ^a   Huh, Yong Min ^a   Lee, Su Jae ^d   Kim, Eui Hyun ^a   Park, Eun Kyung ^a   Kim, Se Hoon ^a   Chang, Jong Hee ^a   Kim, Dong Seok ^a   Kim, Sun Ho ^a   Hong, Yong Kil ^c   Kang, Seok Gu ^a   Lang, Frederick F ^e  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Hanyang University   (South Korea)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CD 105; Glioma stroma; Mesenchymal stemlike cells; Microenvironment; Perivascular area

Indexed keywords

5' NUCLEOTIDASE; CD31 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; PROTEOCHONDROITIN SULFATE; THY 1 ANTIGEN;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; BONE DEVELOPMENT; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; CHONDROGENESIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; PERICYTE; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; RECURRENT CANCER; SOUTH KOREA; STROMA CELL; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; BRAIN NEOPLASMS; CELL SEPARATION; FLOW CYTOMETRY; GLIOMA; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; REPUBLIC OF KOREA;

EID: 84876693644     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-012-1988-1     Document Type: Article

References (59)

1. Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 98(3):603-609
2. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE (1998) Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Anticancer Res 18(3A):1485-1500
3. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267(27):19027-19030
4. Chekenya M, Pilkington GJ (2002) NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. J Neurocytol 31(6-7):507-521
5. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B (2009) Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci 1176:118-123
6. da Silva ML, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(Pt 11):2204-2213
7. Dirks PB (2005) Brain tumor stem cells. Biol Blood Marrow Transplant 11(2 Suppl 2):12-13
8. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317
9. Ehninger D, Wang LP, Klempin F, Romer B, Kettenmann H, Kempermann G (2011) Enriched environment and physical activity reduce microglia and influence the fate of NG2 cells in the amygdala of adult mice. Cell Tissue Res 345(1):69-86
10. El-Haibi CP, Karnoub AE (2011) Mesenchymal stem cells in the pathogenesis and therapy of breast cancer. J Mammary Gland Biol Neoplasia 15(4):399-409
11. Fidler IJ, Poste G (2008) The "seed and soil" hypothesis revisited. Lancet Oncol 9(8):808
12. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64(18):6503-6510
13. Hall B, Andreeff M, Marini F (2007) The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 12(180):263-283
14. He J, Liu Y, Zhu T, Zhu J, Dimeco F, Vescovi AL, Heth JA, Muraszko KM, Fan X, Lubman DM (2012) CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. Mol Cell Proteomics 11(6):M111-010744
15. Hoelzinger DB, Demuth T, Berens ME (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99(21):1583-1593
16. Hoffman S, Propp JM, McCarthy BJ (2006) Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 8(1):27-37
17. Holman DW, Grzybowski DM, Mehta BC, Katz SE, Lubow M (2005) Characterization of cytoskeletal and junctional proteins expressed by cells cultured from human arachnoid granulation tissue. Cerebrospinal Fluid Res 2:9
18. Kang SG, Shinojima N, Hossain A, Gumin J, Yong RL, Colman H, Marini F, Andreeff M, Lang FF (2010) Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 67(3):711-720
19. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162):557-563
20. Kestendjieva S, Kyurkchiev D, Tsvetkova G, Mehandjiev T, Dimitrov A, Nikolov A, Kyurkchiev S (2008) Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int 32(7):724-732
21. Kim SM, Kang SG, Park NR, Mok HS, Huh YM, Lee SJ, Jeun SS, Hong YK, Park CK, Lang FF (2011) Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model. Childs Nerv Syst 27(6):911-922
22. Kong BH, Park NR, Shim JK, Kim BK, Shin HJ, Lee JH, Huh YM, Lee SJ, Kim SH, Kim EH, Park EK, Chang JH, Kim DS, Kim SH, Hong YK, Kang SG, Lang FF (2012) Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens. Childs Nerv Syst. doi: 10.1007/s00381-012-1964-9
23. Lal S, Lacroix M, Tofilon P, Fuller GN, Sawaya R, Lang FF (2000) An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg 92(2):326-333
24. Lang FF, Amano T, Hata N, Gumin J, Aldape K, Colman H (2007) Bone marrow-derived mesenchymal stem cells are recruited to and alter the growth of human gliomas [abstract]. Neuro Oncol 9:596
25. Lang FF, Gumin J, Amano T, Hata N, Heimberger F, Marini F, Andreeff M, Aldape K, Sulman E, Colman H (2008) Tumor-derived mesenchymal stem cells in human gliomas: isolation and biological properties [abstract]. J Clin Oncol 26(suppl) (15S):2001
26. Lee CH, Jung KW, Yoo H, Park S, Lee SH (2010) Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc 48(2):145-152
27. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5):391-403
28. Lennon DP, Caplan AI (2006) Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol 34(11):1604-1605
29. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411(6835):375-379
30. Lopes CA, Mair WG (1974) Tubular structures in arachnoid cells. Acta Neuropathol 27(4):363-368
31. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97-109
32. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F (2001) Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 86(10):1099-1100
33. Marx J (2008) Cancer biology. All in the stroma: cancer's Cosa Nostra. Science 320(5872):38-41
34. Mendoza M, Khanna C (2009) Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41(7):1452-1462
35. Murfee WL, Rehorn MR, Peirce SM, Skalak TC (2006) Perivascular cells along venules upregulate NG2 expression during microvascular remodeling. Microcirculation 13(3):261-273
36. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65(8):3307-3318
37. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11(14):1155-1164
38. Nardi NB (2005) All the adult stem cells, where do they all come from? An external source for organ-specific stem cell pools. Med Hypotheses 64(4):811-817
39. Ng HK, Tse CC, Lo ST (1987) Meningiomas and arachnoid cells: an immunohistochemical study of epithelial markers. Pathology 19(3):253-257
40. Oi S, Matsumoto S, Choi JU, Kang JK, Wong T, Wang C, Chan TS (1990) Brain tumors diagnosed in the first year of life in five Far-Eastern countries. Statistical analysis of 307 cases. Childs Nerv Syst 6(2):79-85
41. Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB (2001) NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 222(2):218-227
42. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 133:571-573
43. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157-173
44. Ricci-Vitiani L, Pallini R, Larocca LM, Lombardi DG, Signore M, Pierconti F, Petrucci G, Montano N, Maira G, De Maria R (2008) Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ 15(9):1491-1498
45. Rieske P, Golanska E, Zakrzewska M, Piaskowski S, Hulas-Bigoszewska K, Wolanczyk M, Szybka M, Witusik-Perkowska M, Jaskolski DJ, Zakrzewski K, Biernat W, Krynska B, Liberski PP (2009) Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors. BMC Cancer 9:54
46. Robertson JT, Gunter BC, Somes GW (2002) Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 16(6):562-566
47. Rutka JT, Giblin JR, Balkissoon R, Wen D, Myatt CA, McCulloch JR, Rosenblum ML (1987) Characterization of fetal human brain cultures. Development of a potential model for selectively purifying human glial cells in culture. Dev Neurosci 9(3):154-173
48. Rutka JT, Kleppe-Hoifodt H, Emma DA, Giblin JR, Dougherty DV, McCulloch JR, De Armond SJ, Rosenblum ML (1986) Characterization of normal human brain cultures. Evidence for the outgrowth of leptomeningeal cells. Lab Invest 55(1):71-85
49. Shin GY, Shim JK, Lee JH, Shin HJ, Lee SJ, Huh YM, Kim EH, Park EK, Kim SH, Chang JH, Kim DS, Hong YK, Kim SH, Kang SG, Lang FF (2012) Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation. Childs Nerv Syst. doi: 10.1007/s00381-012-1963-x
50. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821-5828
51. Stallcup WB (2002) The NG2 proteoglycan: past insights and future prospects. J Neurocytol 31(6-7):423-435
52. Stallcup WB, Huang FJ (2008) A role for the NG2 proteoglycan in glioma progression. Cell Adh Migr 2(3):192-201
53. Stewart PA, Farrell CL, Del Maestro RF (1991) The effect of cellular microenvironment on vessels in the brain. Part 1: vessel structure in tumour, peritumour and brain from humans with malignant glioma. Int J Radiat Biol 60(1-2):125-130
54. Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM, Nelson SF (2006) Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 4(9):607-619
55. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98-110
56. Yao Y, Kubota T, Takeuchi H, Sato K (2005) Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology 25(3):201-206
57. Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC (2005) Isolation of multipotent cells from human term placenta. Stem Cells 23(1):3-9
58. Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S (2008) Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214(2):413-421
59. Zhu L, Xiang P, Guo K, Wang A, Lu J, Tay SS, Jiang H, He BP (2012) Microglia/monocytes with NG2 expression have no phagocytic function in the cortex after LPS focal injection into the rat brain. Glia 60(9):1417-1426